We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.9B
AUM Growth
-$1.19B
Cap. Flow
-$1.27B
Cap. Flow %
-43.75%
Top 10 Hldgs %
34.83%
Holding
644
New
132
Increased
85
Reduced
129
Closed
248

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$44.7M
2
PLD icon
Prologis
PLD
+$36.2M
3
DFS
Discover Financial Services
DFS
+$35.3M
4
TFC icon
Truist Financial
TFC
+$32M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$28.4M

Top Sells

Rank Stock Value
1
SNV
Synovus
SNV
+$27.8M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$25.2M
3
CIVI
Civitas Resources
CIVI
+$24.3M
4
KO icon
Coca-Cola
KO
+$23.5M
5
APC
Anadarko Petroleum
APC
+$22.2M

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Real Estate 14.1%
3 Healthcare 6.11%
4 Industrials 4.83%
5 Technology 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VSLR
376
DELISTED
VIVINT SOLAR, INC.
VSLR
$221K 0.01%
+24,000
New +$274K
APEN
377
DELISTED
Apollo Endosurgery, Inc.
APEN
$212K 0.01%
974
– –
RPTP
378
CALL
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$210K 0.01%
20,000
– –
PCOM
379
DELISTED
Points.com Inc. Common Shares
PCOM
$192K 0.01%
15,000
+5,000
+50% +$70.1K
ACHN
380
DELISTED
Achillion Pharmaceuticals
ACHN
$184K 0.01%
15,000
-10,000
-40% -$122K
PETX
381
CALL
DELISTED
Aratana Therapeutics, Inc.
PETX
$178K 0.01%
+10,000
New +$125K
GERN icon
382
Geron
GERN
$911M
$163K 0.01%
50,000
-25,000
-33% -$69.2K
EHIC
383
DELISTED
eHi Car Services Limited
EHIC
$163K 0.01%
+20,000
New +$208K
GYRE icon
384
Gyre Therapeutics
GYRE
$662M
$145K 0.01%
70
– –
VVUS
385
DELISTED
Vivus Inc
VVUS
$144K 0.01%
5,000
– –
KERX
386
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$142K ﹤0.01%
+10,000
New +$155K
AKAO
387
DELISTED
Achaogen Inc
AKAO
$131K ﹤0.01%
10,000
– –
VIRX
388
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$128K ﹤0.01%
+238
New +$107K
CERS icon
389
CALL
Cerus
CERS
$587M
$125K ﹤0.01%
+20,000
New +$90.8K
AGEN
390
Agenus
AGEN
$249M
$119K ﹤0.01%
1,529
+510
+50% +$31.4K
NVAX icon
391
Novavax
NVAX
$1.23B
$119K ﹤0.01%
1,000
– –
MACK
392
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$113K ﹤0.01%
1,271
-3,813
-75% -$278K
VIRX
393
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$102K ﹤0.01%
+190
New +$85.6K
CYTK icon
394
Cytokinetics
CYTK
$11B
$80K ﹤0.01%
+10,000
New +$42.9K
NSPR icon
395
InspireMD
NSPR
$32M
– –
0
– –
AAT
396
American Assets Trust
AAT
$1.49B
– –
-300,000
Closed -$9.89M
ABUS icon
397
PUT
Arbutus Biopharma
ABUS
$865M
– –
-10,000
Closed -$211K
ACM icon
398
Aecom
ACM
$9.07B
– –
-60,000
Closed -$2.02M
AEP icon
399
American Electric Power
AEP
$73.7B
– –
-174,997
Closed -$9.14M
AFL icon
400
Aflac
AFL
$63.9B
– –
-300,000
Closed -$8.74M
14 15
16
17 18

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q4 2014 Portfolio in Review

As of Q4 2014, Weiss Multi-Strategy Advisers held 644 positions worth $2.9B, down 29% from $4.09B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $1.27B in Q4 2014, closing 248 positions and reducing 129 holdings. Its most notable exit was Coca-Cola Europacific Partners, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 12% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Capital One worth $45.4M.

  • Weiss Multi-Strategy Advisers's largest Q4 2014 buy was Capital One: 550,000 shares worth $45.4M.
  • Weiss Multi-Strategy Advisers added most to Prologis in Q4 2014, an estimated $36.2M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2014 reduction was Synovus, cutting an estimated $27.8M.
  • Weiss Multi-Strategy Advisers fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $25.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 35% of its $2.9B portfolio in Q4 2014.
  • Weiss Multi-Strategy Advisers opened 132 new positions and closed 248 in Q4 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 29% quarter-over-quarter to $2.9B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.